Researchers developed PTF-loaded solid lipid nanoparticles (PTF-SLNs) for treating lung cancer. PTF-SLNs showed stronger anti-tumor efficacy and reduced harm to normal organs compared to PTF alone. This study offers a potential nanoparticle delivery system to enhance lung cancer treatment.
Emodin-8-glucoside, derived from emodin, shows potential as an antitumor compound in neuroblastoma and glioblastoma cells, inhibiting cell viability and proliferation in a dose-dependent manner. It could be a promising therapy for nervous system tumors.
A study found that extracts contain two flavonoids with antioxidant properties, particularly in the ethyl acetate extract. The extract also showed potential as an anticancer agent by reducing cell viability and inducing apoptosis.
Researchers investigated the effects of an immunopotentiator called CPG on the immune response in tumor-bearing mice. Results showed that CPG inhibited tumor growth, enhanced immune responses, and induced tumor cell death. These findings contribute to our understanding of the immune system's role in fighting tumors.
Extracted from Rosa roxburghii Tratt fruit, polysaccharides RP1 and RP3 induce apoptosis of breast cancer cells. Potential for functional foods or pharmaceutical products for breast cancer treatment.
Piperlongumine inhibits breast cancer cells, induces apoptosis, and impacts signaling pathways. Its potential in cancer treatment is enhanced by nanotechnology. Future research is needed to understand its chemistry, bioavailability, and toxicity.
The study analyzed the heavy metal content and saponins in a Chinese medicinal plant (var.) used for centuries. They found that high heavy metal content reduced the anti-breast cancer activity. Controlling heavy metal content is important in cultivating var. for medicinal purposes.
Solanum nigrum water extract (SNWE) showed significant anticancer effects against MCF-7 and MDA-MB-231 breast cancer cells by inducing apoptotic cell death. This suggests that SNWE could be a potential non-toxic treatment option for breast cancer, but more research is needed.